4-108009883-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005327.7(HADH):​c.257T>C​(p.Leu86Pro) variant causes a missense change. The variant allele was found at a frequency of 0.914 in 1,607,364 control chromosomes in the GnomAD database, including 674,453 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.87 ( 57994 hom., cov: 29)
Exomes 𝑓: 0.92 ( 616459 hom. )

Consequence

HADH
NM_005327.7 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.87

Publications

47 publications found
Variant links:
Genes affected
HADH (HGNC:4799): (hydroxyacyl-CoA dehydrogenase) This gene is a member of the 3-hydroxyacyl-CoA dehydrogenase gene family. The encoded protein functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene of this gene on chromosome 15. [provided by RefSeq, May 2010]
HADH Gene-Disease associations (from GenCC):
  • 3-hydroxyacyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, ClinGen
  • hyperinsulinemic hypoglycemia, familial, 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.211664E-7).
BP6
Variant 4-108009883-T-C is Benign according to our data. Variant chr4-108009883-T-C is described in ClinVar as Benign. ClinVar VariationId is 167162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.949 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HADHNM_005327.7 linkc.257T>C p.Leu86Pro missense_variant Exon 2 of 8 ENST00000309522.8 NP_005318.6
HADHNM_001184705.4 linkc.257T>C p.Leu86Pro missense_variant Exon 2 of 9 NP_001171634.3
HADHNM_001331027.2 linkc.269T>C p.Leu90Pro missense_variant Exon 2 of 8 NP_001317956.2
HADHXR_007096395.1 linkn.301T>C non_coding_transcript_exon_variant Exon 2 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HADHENST00000309522.8 linkc.257T>C p.Leu86Pro missense_variant Exon 2 of 8 1 NM_005327.7 ENSP00000312288.4

Frequencies

GnomAD3 genomes
AF:
0.867
AC:
131686
AN:
151928
Hom.:
57953
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.696
Gnomad AMI
AF:
0.946
Gnomad AMR
AF:
0.931
Gnomad ASJ
AF:
0.975
Gnomad EAS
AF:
0.972
Gnomad SAS
AF:
0.902
Gnomad FIN
AF:
0.963
Gnomad MID
AF:
0.943
Gnomad NFE
AF:
0.923
Gnomad OTH
AF:
0.893
GnomAD2 exomes
AF:
0.921
AC:
231638
AN:
251446
AF XY:
0.921
show subpopulations
Gnomad AFR exome
AF:
0.695
Gnomad AMR exome
AF:
0.963
Gnomad ASJ exome
AF:
0.975
Gnomad EAS exome
AF:
0.975
Gnomad FIN exome
AF:
0.961
Gnomad NFE exome
AF:
0.926
Gnomad OTH exome
AF:
0.931
GnomAD4 exome
AF:
0.919
AC:
1338010
AN:
1455316
Hom.:
616459
Cov.:
34
AF XY:
0.919
AC XY:
665677
AN XY:
724400
show subpopulations
African (AFR)
AF:
0.694
AC:
23133
AN:
33338
American (AMR)
AF:
0.959
AC:
42881
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.975
AC:
25437
AN:
26088
East Asian (EAS)
AF:
0.968
AC:
38413
AN:
39676
South Asian (SAS)
AF:
0.896
AC:
77170
AN:
86118
European-Finnish (FIN)
AF:
0.960
AC:
51250
AN:
53410
Middle Eastern (MID)
AF:
0.910
AC:
5241
AN:
5758
European-Non Finnish (NFE)
AF:
0.921
AC:
1019211
AN:
1106048
Other (OTH)
AF:
0.919
AC:
55274
AN:
60160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4760
9520
14280
19040
23800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21356
42712
64068
85424
106780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.867
AC:
131787
AN:
152048
Hom.:
57994
Cov.:
29
AF XY:
0.871
AC XY:
64705
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.697
AC:
28852
AN:
41408
American (AMR)
AF:
0.931
AC:
14239
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.975
AC:
3385
AN:
3472
East Asian (EAS)
AF:
0.972
AC:
5021
AN:
5166
South Asian (SAS)
AF:
0.902
AC:
4348
AN:
4820
European-Finnish (FIN)
AF:
0.963
AC:
10181
AN:
10574
Middle Eastern (MID)
AF:
0.942
AC:
277
AN:
294
European-Non Finnish (NFE)
AF:
0.923
AC:
62735
AN:
68004
Other (OTH)
AF:
0.894
AC:
1886
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
795
1590
2385
3180
3975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.910
Hom.:
276794
Bravo
AF:
0.859
TwinsUK
AF:
0.916
AC:
3398
ALSPAC
AF:
0.920
AC:
3546
ESP6500AA
AF:
0.704
AC:
3104
ESP6500EA
AF:
0.924
AC:
7944
ExAC
AF:
0.915
AC:
111095
Asia WGS
AF:
0.923
AC:
3211
AN:
3478
EpiCase
AF:
0.926
EpiControl
AF:
0.928

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 16, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deficiency of 3-hydroxyacyl-CoA dehydrogenase Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.039
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
15
DANN
Benign
0.14
DEOGEN2
Benign
0.13
.;.;T;.;.
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.048
N
LIST_S2
Benign
0.12
T;T;T;T;T
MetaRNN
Benign
7.2e-7
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-2.0
.;N;N;.;.
PhyloP100
4.9
PrimateAI
Benign
0.48
T
PROVEAN
Benign
5.9
.;.;N;N;.
REVEL
Benign
0.27
Sift
Benign
1.0
.;.;T;T;.
Sift4G
Benign
0.71
.;T;T;.;T
Polyphen
0.0
.;.;B;.;.
Vest4
0.050, 0.047, 0.074
MPC
0.38
ClinPred
0.0075
T
GERP RS
4.3
Varity_R
0.19
gMVP
0.54
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4956145; hg19: chr4-108931039; COSMIC: COSV107368533; COSMIC: COSV107368533; API